Coverage with the First Dose of Human Papillomavirus Vaccination among Females Aged 9–50 Years in Shenzhen, China: A Surveillance Based on Administrative Health Records in 2023
Zian Lin,
Xue Liang,
Lixian Su,
Weijun Peng,
Hongbiao Chen,
Yuan Fang,
Siyu Chen,
Weikang Yang,
Wensheng Chen,
Lijun Zhang,
Zixin Wang
Affiliations
Zian Lin
Shenzhen Longhua District Maternity and Child Healthcare Hospital, Shenzhen 518000, China
Xue Liang
Centre for Health Behavious Research, JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR 999077, China
Lixian Su
Shenzhen Futian District Maternity and Child Healthcare Hospital, Shenzhen 518000, China
Weijun Peng
Department of Epidemiology and Infectious Disease Control, Longhua Key Discipline of Public Health for the Prevention and Control of Infectious Diseases, Longhua Centre for Disease Control and Prevention, Shenzhen 518000, China
Hongbiao Chen
Department of Epidemiology and Infectious Disease Control, Longhua Key Discipline of Public Health for the Prevention and Control of Infectious Diseases, Longhua Centre for Disease Control and Prevention, Shenzhen 518000, China
Yuan Fang
Department of Health and Physical Education, The Education University of Hong Kong, Hong Kong SAR 999077, China
Siyu Chen
Centre for Health Behavious Research, JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR 999077, China
Weikang Yang
Shenzhen Longhua District Maternity and Child Healthcare Hospital, Shenzhen 518000, China
Wensheng Chen
Shenzhen Longhua District Maternity and Child Healthcare Hospital, Shenzhen 518000, China
Lijun Zhang
Shenzhen Longhua District Maternity and Child Healthcare Hospital, Shenzhen 518000, China
Zixin Wang
Centre for Health Behavious Research, JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR 999077, China
China started to offer human papillomavirus (HPV) vaccines to females aged 9–45 years in 2016. However, there was a lack of reports about HPV vaccination coverage in a representative sample of females in China. Therefore, this study aimed to examine the current HPV coverage and associated factors among females aged 9–50 years in Shenzhen, China, based on administrative health records kept by community health centers. A multistage random sampling approach was used. The research team randomly selected 18 community health centers in Shenzhen, and 3118 health records of females aged 9–50 years were then randomly selected from these health centers. Among all participants, 18.7% received at least one dose of HPV vaccination. The highest coverage was observed among females aged 18–26 years (23.4%), followed by those aged 27–35 years (22.0%) and 36–45 years (20.2%). Such coverage was very low among females aged 9–17 years (4.6%) and those aged 46–50 years (3.2%). Among females aged 18 years or above, higher education level, having a family doctor, and permanent residency in Shenzhen were associated with higher HPV vaccination coverage, while older age and being married/divorced were negatively associated with coverage. The HPV vaccination coverage in Shenzhen was 18.7% and there is a strong need for improvement.
